• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β1/Smad7在肠道免疫、炎症和癌症中的作用

Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer.

作者信息

Troncone Edoardo, Marafini Irene, Stolfi Carmine, Monteleone Giovanni

机构信息

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

出版信息

Front Immunol. 2018 Jun 20;9:1407. doi: 10.3389/fimmu.2018.01407. eCollection 2018.

DOI:10.3389/fimmu.2018.01407
PMID:29973939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6019438/
Abstract

In physiological conditions, the activity of the intestinal immune system is tightly regulated to prevent tissue-damaging reactions directed against components of the luminal flora. Various factors contribute to maintain immune homeostasis and diminished production and/or function of such molecules trigger and/or propagate detrimental signals, which can eventually lead to chronic colitis and colon cancer. One such a molecule is transforming growth factor-β1 (TGF-β1), a cytokine produced by many inflammatory and non-inflammatory cells and targeting virtually all the intestinal mucosal cell types, with the down-stream effect of activating intracellular Smad2/3 proteins and suppressing immune reactions. In patients with inflammatory bowel diseases (IBD), there is defective TGF-β1/Smad signaling due to high Smad7, an inhibitor of TGF-β1 activity. Indeed, knockdown of Smad7 with a specific antisense oligonucleotide restores endogenous TGF-β1 activity, thereby inhibiting inflammatory pathways in patients with IBD and colitic mice. Consistently, mice over-expressing Smad7 in T cells develop severe intestinal inflammation in various experimental models. Smad7 expression is also upregulated in colon cancer cells, in which such a protein controls positively intracellular pathways that sustain neoplastic cell growth and survival. We here review the role of TGF-β1 and Smad7 in intestinal immunity, inflammation, and cancer.

摘要

在生理条件下,肠道免疫系统的活性受到严格调控,以防止针对管腔菌群成分的组织损伤反应。多种因素有助于维持免疫稳态,而此类分子产生和/或功能的减弱会触发和/或传播有害信号,最终可能导致慢性结肠炎和结肠癌。其中一种这样的分子是转化生长因子-β1(TGF-β1),它是一种由许多炎性和非炎性细胞产生的细胞因子,几乎作用于所有肠道黏膜细胞类型,具有激活细胞内Smad2/3蛋白并抑制免疫反应的下游效应。在炎症性肠病(IBD)患者中,由于TGF-β1活性抑制剂Smad7水平升高,导致TGF-β1/Smad信号传导缺陷。事实上,用特异性反义寡核苷酸敲低Smad7可恢复内源性TGF-β1活性,从而抑制IBD患者和结肠炎小鼠的炎症途径。同样,在各种实验模型中,T细胞中过表达Smad7的小鼠会发生严重的肠道炎症。Smad7在结肠癌细胞中的表达也上调,在这些细胞中,这种蛋白正向调控维持肿瘤细胞生长和存活的细胞内途径。我们在此综述TGF-β1和Smad7在肠道免疫、炎症和癌症中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d0/6019438/a8db58987f17/fimmu-09-01407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d0/6019438/5a21ba45857d/fimmu-09-01407-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d0/6019438/a8db58987f17/fimmu-09-01407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d0/6019438/5a21ba45857d/fimmu-09-01407-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d0/6019438/a8db58987f17/fimmu-09-01407-g001.jpg

相似文献

1
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer.转化生长因子-β1/Smad7在肠道免疫、炎症和癌症中的作用
Front Immunol. 2018 Jun 20;9:1407. doi: 10.3389/fimmu.2018.01407. eCollection 2018.
2
Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer.Smad7 在肠道炎症性疾病和结肠癌中的作用。
Int J Mol Sci. 2021 Apr 10;22(8):3922. doi: 10.3390/ijms22083922.
3
Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.阻断Smad7可恢复慢性炎症性肠病中的TGF-β1信号传导。
J Clin Invest. 2001 Aug;108(4):601-9. doi: 10.1172/JCI12821.
4
Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases.Smad7及其作为炎症性肠病治疗靶点的潜力。
Curr Drug Metab. 2016;17(3):303-6. doi: 10.2174/1389200217666151210130103.
5
The TGF-β/Smad System in IBD Pathogenesis.IBD发病机制中的转化生长因子-β/ Smad系统
Inflamm Bowel Dis. 2015 Dec;21(12):2921-5. doi: 10.1097/MIB.0000000000000542.
6
Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis.用特异性反义寡核苷酸抑制Smad7可促进转化生长因子β1介导的对结肠炎的抑制作用。
Gastroenterology. 2006 Dec;131(6):1786-98. doi: 10.1053/j.gastro.2006.09.016. Epub 2006 Sep 19.
7
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice.用特异性反义寡核苷酸敲低 Smad7 可减轻小鼠结肠炎和结肠炎驱动的结肠纤维化。
Inflamm Bowel Dis. 2018 May 18;24(6):1213-1224. doi: 10.1093/ibd/izy062.
8
TGF-Beta signaling manipulation as potential therapy for IBD.TGF-β 信号转导调控作为 IBD 的潜在治疗方法。
Curr Drug Targets. 2013 Nov;14(12):1400-4. doi: 10.2174/13894501113149990157.
9
TGF-beta1 and Smad7 in the regulation of IBD.转化生长因子-β1和Smad7在炎症性肠病调控中的作用
Mucosal Immunol. 2008 Nov;1 Suppl 1:S50-3. doi: 10.1038/mi.2008.55.
10
Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseases.基于 Smad7 反义寡核苷酸的炎症性肠病治疗。
Dig Liver Dis. 2013 Jul;45(7):552-5. doi: 10.1016/j.dld.2012.11.011. Epub 2013 Jan 1.

引用本文的文献

1
Red meat intake interacts with a TGF-β-pathway-based polygenic risk score to impact colorectal cancer risk: Application of a novel approach for polygenic risk score construction.红肉摄入量与基于转化生长因子-β通路的多基因风险评分相互作用,影响结直肠癌风险:一种构建多基因风险评分新方法的应用
medRxiv. 2025 Jun 16:2025.06.13.25329599. doi: 10.1101/2025.06.13.25329599.
2
An In Silico Study of Transforming Growth Factor-β Inhibitors: A Potential Target for Diabetic Nephropathy Treatment with Active Compounds from the Active Fraction of Physalis angulata.酸浆活性部位活性化合物治疗糖尿病肾病的潜在靶点——转化生长因子-β抑制剂的计算机模拟研究
Int J Mol Cell Med. 2024;13(3):234-247. doi: 10.22088/IJMCM.BUMS.13.3.234.
3

本文引用的文献

1
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice.用特异性反义寡核苷酸敲低 Smad7 可减轻小鼠结肠炎和结肠炎驱动的结肠纤维化。
Inflamm Bowel Dis. 2018 May 18;24(6):1213-1224. doi: 10.1093/ibd/izy062.
2
Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's Disease.蒙吉森(GED-0301)治疗活动期克罗恩病患者的内镜和临床结局的影响。
Gastroenterology. 2018 Jan;154(1):61-64.e6. doi: 10.1053/j.gastro.2017.08.035. Epub 2017 Aug 25.
3
Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets.
Combination of Lactiplantibacillus Plantarum ELF051 and Astragalus Polysaccharides Improves Intestinal Barrier Function and Gut Microbiota Profiles in Mice with Antibiotic-Associated Diarrhea.
植物乳杆菌ELF051与黄芪多糖联合改善抗生素相关性腹泻小鼠的肠道屏障功能和肠道微生物群特征。
Probiotics Antimicrob Proteins. 2024 Oct 1. doi: 10.1007/s12602-024-10368-3.
4
Effects of DNA methylation and its application in inflammatory bowel disease (Review).DNA 甲基化的影响及其在炎症性肠病中的应用(综述)。
Int J Mol Med. 2024 Jun;53(6). doi: 10.3892/ijmm.2024.5379. Epub 2024 May 2.
5
Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR-21-3p/SMAD7 axis.环状 RNA circWNK1 通过调控 miR-21-3p/SMAD7 轴抑制胃癌的进展。
Cancer Sci. 2024 Mar;115(3):974-988. doi: 10.1111/cas.16067. Epub 2024 Jan 29.
6
Colorectal Cancer Risk Prediction Using the rs4939827 Polymorphism of the Gene in the Romanian Population.利用罗马尼亚人群中该基因的rs4939827多态性预测结直肠癌风险
Diagnostics (Basel). 2024 Jan 19;14(2):220. doi: 10.3390/diagnostics14020220.
7
A predictive model for early death in elderly colorectal cancer patients: a population-based study.老年结直肠癌患者早期死亡的预测模型:一项基于人群的研究。
Front Oncol. 2023 Dec 18;13:1278137. doi: 10.3389/fonc.2023.1278137. eCollection 2023.
8
A tryptophan metabolite made by a gut microbiome eukaryote induces pro-inflammatory T cells.肠道微生物组真核生物产生的色氨酸代谢物可诱导促炎 T 细胞。
EMBO J. 2023 Nov 2;42(21):e112963. doi: 10.15252/embj.2022112963. Epub 2023 Sep 25.
9
Protective Effect of Essential Oil against K99-Induced Intestinal Barrier Injury in Mice.精油对 K99 诱导的小鼠肠道屏障损伤的保护作用。
Nutrients. 2023 Jun 9;15(12):2697. doi: 10.3390/nu15122697.
10
Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β, -TGM.源自蠕虫的转化生长因子-β免疫调节模拟物-TGM对T细胞依赖性结肠炎的保护作用。
Discov Immunol. 2023 Jan 18;2(1):kyad001. doi: 10.1093/discim/kyad001. eCollection 2023.
主要转录因子之间的动态平衡决定了CD4 T细胞和固有淋巴细胞亚群的命运与功能。
J Exp Med. 2017 Jul 3;214(7):1861-1876. doi: 10.1084/jem.20170494. Epub 2017 Jun 19.
4
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide.CCL20 在肠上皮细胞中受 TGF-β1 负调控,并在对 Smad7 反义寡核苷酸 Mongersen 治疗有应答的克罗恩病患者中减少。
J Crohns Colitis. 2017 May 1;11(5):603-609. doi: 10.1093/ecco-jcc/jjw191.
5
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death.Smad7基因敲低激活与蛋白激酶RNA相关的eIF2α途径,导致结肠癌细胞死亡。
Cell Death Dis. 2017 Mar 16;8(3):e2681. doi: 10.1038/cddis.2017.103.
6
NR2F2 inhibits Smad7 expression and promotes TGF-β-dependent epithelial-mesenchymal transition of CRC via transactivation of miR-21.NR2F2通过miR-21的反式激活抑制Smad7表达并促进结直肠癌中TGF-β依赖的上皮-间质转化。
Biochem Biophys Res Commun. 2017 Mar 25;485(1):181-188. doi: 10.1016/j.bbrc.2017.02.049. Epub 2017 Feb 10.
7
SMAD7 polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.SMAD7基因多态性与结直肠癌风险:病例对照研究的荟萃分析
Oncotarget. 2016 Nov 15;7(46):75561-75570. doi: 10.18632/oncotarget.12285.
8
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 32 种癌症组别的伤残调整生命年数,1990 年至 2015 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2017 Apr 1;3(4):524-548. doi: 10.1001/jamaoncol.2016.5688.
9
Do antibodies select a healthy microbiota?抗体是否会选择健康的微生物群?
Nat Rev Immunol. 2016 Dec;16(12):767-774. doi: 10.1038/nri.2016.114. Epub 2016 Nov 7.
10
TGF-β Signaling in Dendritic Cells Governs Colonic Homeostasis by Controlling Epithelial Differentiation and the Luminal Microbiota.树突状细胞中的TGF-β信号通过控制上皮分化和管腔微生物群来维持结肠稳态。
J Immunol. 2016 Jun 1;196(11):4603-13. doi: 10.4049/jimmunol.1502548. Epub 2016 Apr 22.